Skip to main content
Xiaohan Yang is using his expertise in synthetic biology and capabilities like the Advanced Plant Phenotyping Laboratory at Oak Ridge National Laboratory to accelerate the development of drought-tolerant, fast-growing bioenergy crops suited for conversion into clean jet fuels. Credit: Genevieve Martin/ORNL, U.S. Dept. of Energy

Scientist Xiaohan Yang’s research at the Department of Energy’s Oak Ridge National Laboratory focuses on transforming plants to make them better sources of renewable energy and carbon storage.

Connecting  wires to the interface of the topological insulator and superconductor enables probing of novel electronic properties. Researchers aim for qubits based on theorized Majorana particles. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy

Quantum computers process information using quantum bits, or qubits, based on fragile, short-lived quantum mechanical states. To make qubits robust and tailor them for applications, researchers from the Department of Energy’s Oak Ridge National Laboratory sought to create a new material system.

Conceptual art depicts an atomic nucleus and merging neutron stars, respectively, areas of study in ORNL-led projects called NUCLEI and ENAF within the Scientific Discovery through Advanced Computing, or SciDAC, program. Credit: Adam Malin/ORNL, U.S. Dept. of Energy

ORNL is leading two nuclear physics research projects within the Scientific Discovery through Advanced Computing, or SciDAC, program from the Department of Energy Office of Science.

The DEMAND single crystal diffractometer at the High Flux Isotope Reactor, or HFIR, is the latest neutron instrument at the Department of Energy’s Oak Ridge National Laboratory to be equipped with machine learning-assisted software, called ReTIA. Credit: Jeremy Rumsey/ORNL, U.S. Dept. of Energy

Neutron experiments can take days to complete, requiring researchers to work long shifts to monitor progress and make necessary adjustments. But thanks to advances in artificial intelligence and machine learning, experiments can now be done remotely and in half the time.

oxygen isotope 28

Rare isotope oxygen-28 has been determined to be "barely unbound" by experiments led by researchers at the Tokyo Institute of Technology and by computer simulations conducted at ORNL. The findings from this first-ever observation of 28O answer a longstanding question in nuclear physics: can you get bound isotopes in a very neutron-rich region of the nuclear chart, where instability and radioactivity are the norm? 

Madhavi Martin portrait image

Madhavi Martin brings a physicist’s tools and perspective to biological and environmental research at the Department of Energy’s Oak Ridge National Laboratory, supporting advances in bioenergy, soil carbon storage and environmental monitoring, and even helping solve a murder mystery.

The OpeN-AM experimental platform, installed at the VULCAN instrument, features a robotic arm that prints layers of molten metal to create complex shapes. Credit: Jill Hemman/ORNL, U.S Dept. of Energy

Technologies developed by researchers at ORNL have received six 2023 R&D 100 Awards.  

A beam of excited sodium-32 nuclei implants in the FRIB Decay Station initiator is used to detect decay signatures of isotopes. Credit: Gary Hollenhead, Toby King and Adam Malin/ORNL, U.S. Dept. of Energy

Timothy Gray of ORNL led a study that may have revealed an unexpected change in the shape of an atomic nucleus. The surprise finding could affect our understanding of what holds nuclei together, how protons and neutrons interact and how elements form.

Group of young kids sitting at a lab table.

A group at the Department of Energy's Oak Ridge National Laboratory made a difference for local youth through hands-on projects that connected neutron science and engineering intuitively.

Neutron experiments helped reveal the one-carbon enzymatic mechanism that synthesizes vital food sources for cancer cells that depend on vitamin B6, providing key insights into designing novel drugs to slow the spread of aggressive cancers. Credit: Jill Hemman/ORNL, U.S. Dept. of Energy

After a highly lauded research campaign that successfully redesigned a hepatitis C drug into one of the leading drug treatments for COVID-19, scientists at ORNL are now turning their drug design approach toward cancer.